Actual data on health care provision for children and adolescents with ADHD in Germany - Administrative prevalence, involved groups of physicians and medical therapies;Aktuelle daten zur medizinischen versorgung von kindern und jugendlichen mit ADHS in Deutschland: Administrative prävalenz, beteiligte arztgruppen und arzneimitteltherapie

PsychoNeuro

Volumn 33, Issue 10, 2007, Pages 412-415

  Schlander, Michael ^a  

^a Institute for Innovation and Valuation in Health Care   (Germany)

Author keywords

ADHD; Conduct disorder; Methylphenidate; Overuse; Prevalence; Treatment

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CHILD CARE; CONDUCT DISORDER; CONTROLLED STUDY; DRUG USE; GERMANY; HEALTH CARE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE; PHYSICIAN; PREVALENCE; REVIEW;

EID: 36349036508     PISSN: 16119991     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993824     Document Type: Review

References (17)

1. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Association, 1994
2. Brownell MD, Yogendran MS. Can J Psychiatry 2001; 46 (3): 264-272
3. Buitelaar JK, Rothenberger A. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1: 1-6
4. DeGrandpre RJ. Ritalin nation: rapid-fire-culture and the transformation of human consciousness. New York: Norton, 2000
5. Faraone SV et al. World Psychiatry 2003; 2 (2): 104-113
6. Kelleher KJ et al. Pediatrics 200; 105 (6): 1313-1321
7. Köster I et al. Zeitschrift fuer Kinder- und Jugendpsychiatrie und Psychotherapie 2004; 32: 157-166
8. Rappley MD. Attention deficit-hyperactivity disorder. N Eng J Med 2005; 352 (2): 165-173
9. Scahill L, Schwab-Stone M. Child Adolesc Psychiatr Clin N Ame 2000; 9 (3): 541-555
10. Schlander M. Child Adolesc Psychiatry Ment Health 2007, in press
11. Schlander M, Schwarz O. J Ment Health Policy Econ 2007; 10 (Suppl 1): S36-S37
12. Schlander M et al. Eur Child Adolesc Psychiatry 2007, epub ahead of print: DOI 10.1007/s00787-007-0615-2,1-10
13. Schlander M et al. Value in Health 2006; 9 (6) A191-A192
14. Schubert I et al. Methylphenidat-Verordnungsanalyse auf der Basis von GKV-Daten, Wissenschaftliches Institut der AOK (WidO; Hrsg.), Bonn 2002
15. Schwabe U, Paffrath D. Arzneiverordnungs-Report 2006. Heidelberg: Springer Verlag 2006
16. Taylor E et al. Eur Child Adolesc Psychiatry 2004; 13 (Suppl 1): 7-30
17. World Health Organization. International statistical classification of diseases and related health problems (ICD-10). Genève: The World Health Organization, 1992